Latest News

Date Title Topic
14 Oct 2019 Patient Guide in Breast Cancer Now Available In Serbian
09 Oct 2019 European Lung Cancer Congress 2020
08 Oct 2019 How To Ensure That Novel Analytic Methods Are Fit for Decision-Making Bioethics, legal and economic issues
04 Oct 2019 ESMO Congress 2019 News
02 Oct 2019 ESMO Clinical Practice Guidelines
01 Oct 2019 Certificate of attendance
30 Sep 2019 Adding Atezolizumab to Front-Line Platinum-Based Chemotherapy Improves Progression-Free Survival in mUC Genitourinary cancers - Cancer Immunology and Immunotherapy - Anticancer agents & Biologic therapy
30 Sep 2019 Olaparib Outperforms Enzalutamide or Abiraterone Acetate in Men with mCRPC and HRR Alterations Genitourinary cancers - Personalised medicine - Anticancer agents & Biologic therapy
30 Sep 2019 Ivosidenib Provides Prolonged Progression-Free Survival in Patients with Cholangiocarcinoma and IDH1 Mutation Gastrointestinal cancers - Personalised medicine - Anticancer agents & Biologic therapy
30 Sep 2019 First Report of Head and Neck Squamous Cell Carcinoma Treatment Individualised by Geriatric Assessment Head and neck cancers - Cancer in Special Situations / Population
29 Sep 2019 Significant PFS Benefit Observed with Veliparib plus Carboplatin and Paclitaxel in Patients with Advanced HER2-negative Breast Cancer and BRCA1/2 Mutations Breast cancer - Anticancer agents & Biologic therapy
29 Sep 2019 Adding Pembrolizumab to Neoadjuvant Chemotherapy Improves Outcome in Early TNBC Breast cancer - Cancer Immunology and Immunotherapy - Anticancer agents & Biologic therapy
29 Sep 2019 Final FLAURA Results Demonstrate Overall Survival Benefit with Osimertinib Over TKIs in Advanced NSCLC Lung and other thoracic tumours - Personalised medicine - Anticancer agents & Biologic therapy
29 Sep 2019 Dual HER2 Blockade in Patients With HER2-Amplified Metastatic Colorectal Cancer Gastrointestinal cancers - Personalised medicine - Anticancer agents & Biologic therapy
29 Sep 2019 First-Line Pembrolizumab Versus Chemotherapy in Patients with Advanced G/GEJ Cancer Demonstrates Similar Survival and HRQoL Gastrointestinal cancers - Cancer Immunology and Immunotherapy - Anticancer agents & Biologic therapy